MaxLinear had its Relative Strength (RS) Rating upgraded from 64 to 75 Monday — a welcome improvement, but still short of the 80 or better score you look for.
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
History shows that the market's biggest winners tend to have an 80 or better RS Rating in the early stages of their moves. See if MaxLinear can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
While now is not an ideal time to invest, see if the stock is able to offer and clear an appropriate buy point.
MaxLinear posted 0% EPS growth in its most recent report, while sales growth came in at -40%.
MaxLinear earns the No. 25 rank among its peers in the Electronics-Semiconductor Fabless industry group. NVIDIA, Rambus and SiTime are among the top 5 highly rated stocks within the group.
RELATED:
Chip Stocks To Watch And Semiconductor Industry News
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
